I have been a shareholder for a long time because of the...

I have been a shareholder for a long time because of the tremendously exciting potential in BOS technology. In the Biosignal News publication for August 2007, director Prof Gunter Pauli cited influential American entreprener Paul Hawken, saying the future potential of Biosignal's products is $10B.

Yes, its worth billions. Setbacks with surface attachment to contact lens and catheter applications caused many investors to throw up their hands in despair, however, I do believe that the patient investor will be rewarded not only financially but will also have the personal satisfaction of being on the ground floor in backing a world class technology with myriad opportunities.

So good to see some greater depth in investor interest given the recent announcement.